Your session is about to expire
← Back to Search
CGM for Type 2 Diabetes (CMGProject Trial)
N/A
Waitlist Available
Led By Thomas Grace, MD
Research Sponsored by Blanchard Valley Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosis of T2DM
Age 18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 months
Awards & highlights
CMGProject Trial Summary
This trial looks at whether using RT-CGM instead of SMBG can help Type 2 Diabetics manage their glucose levels better and improve their quality of life.
Who is the study for?
Adults with Type 2 Diabetes not meeting their A1C goals (A1C ≥7.7%) despite regular doctor visits and a desire to improve control are eligible for this trial. They must be willing to wear a continuous glucose monitor (CGM) and have stable diabetes management, as judged by the investigator. Pregnant individuals, those with certain medical conditions or severe allergies to adhesives, and anyone using CGMs in the last 3 months are excluded.Check my eligibility
What is being tested?
The study is testing if real-time continuous glucose monitoring (RT-CGM) can better manage blood sugar levels compared to standard self-monitoring in people with Type 2 Diabetes who aren't reaching their target A1C levels. It also looks at how RT-CGM affects quality of life.See study design
What are the potential side effects?
While there may not be direct side effects from using a CGM device like Dexcom G6, potential issues include skin irritation from adhesive patches, discomfort or pain at the sensor site, and possible inaccuracies leading to mismanagement of insulin doses.
CMGProject Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with type 2 diabetes.
Select...
I am 18 years old or older.
CMGProject Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
A1c
Secondary outcome measures
BMI
Percent Time in Hyperglycemia (>180 mg/dl)
Percent Time in Hypoglycemia (<70 mg/dl)
+3 moreCMGProject Trial Design
1Treatment groups
Experimental Treatment
Group I: Treatment ArmExperimental Treatment1 Intervention
All participants will be given a rtCGM (Dexcom G6) to assess their glycemic control.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dexcom G6 CGM
2019
N/A
~320
Find a Location
Who is running the clinical trial?
Blanchard Valley Health SystemLead Sponsor
Thomas Grace, MDPrincipal InvestigatorHancock County Health Department
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been using a real-time CGM device for the last 3 months.I have been diagnosed with type 2 diabetes.My blood sugar control is poor, with an A1C level of 7.7% or higher.My diabetes is under control as confirmed by my doctor.I am 18 years old or older.My kidney function is reduced with an eGFR below 45.I cannot wear a sensor due to extensive skin issues.I want to lower my A1C to a goal of 7%.My doctor thinks aiming for an A1C under 7% is unsafe for me.I am using or will use steroids that could affect my blood sugar levels.
Research Study Groups:
This trial has the following groups:- Group 1: Treatment Arm
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this trial currently enrolling participants?
"As per the data on clinicaltrials.gov, this study is no longer searching for new patients as it last updated its status in March 7th 2023. Despite that fact, 397 other studies are still open and recruiting participants."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger